Spots Global Cancer Trial Database for stage i melanoma
Every month we try and update this database with for stage i melanoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma | NCT00049010 | Melanoma (Skin) | comparative gen... cytogenetic ana... fluorescence in... immunohistochem... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma | NCT00060333 | Recurrent Melan... | radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Vaccine Therapy in Treating Patients With Melanoma | NCT00020358 | Melanoma (Skin) | aldesleukin gp100 antigen incomplete Freu... tyrosinase pept... | 16 Years - | National Cancer Institute (NCI) | |
Vaccine Therapy in Treating Patients With Melanoma | NCT00020358 | Melanoma (Skin) | aldesleukin gp100 antigen incomplete Freu... tyrosinase pept... | 16 Years - | National Cancer Institute (NCI) | |
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members | NCT00346008 | Melanoma (Skin) | mutation analys... high performanc... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis | NCT00004196 | Melanoma (Skin) | recombinant int... lymphangiograph... Observation | 18 Years - 70 Years | University of Alabama at Birmingham | |
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members | NCT00346008 | Melanoma (Skin) | mutation analys... high performanc... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma | NCT00060333 | Recurrent Melan... | radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Boron Neutron Capture Therapy in Treating Patients With Melanoma | NCT00059800 | Melanoma (Skin) | boron neutron c... | 18 Years - | National Cancer Institute (NCI) | |
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis | NCT00004196 | Melanoma (Skin) | recombinant int... lymphangiograph... Observation | 18 Years - 70 Years | University of Alabama at Birmingham | |
Lovastatin in Treating Patients At High Risk of Melanoma | NCT00462280 | Precancerous Co... Stage 0 Melanom... Stage I Melanom... Stage II Melano... | lovastatin placebo biopsy laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Lovastatin in Treating Patients At High Risk of Melanoma | NCT00462280 | Precancerous Co... Stage 0 Melanom... Stage I Melanom... Stage II Melano... | lovastatin placebo biopsy laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma | NCT00004153 | Melanoma (Skin) | reverse transcr... sentinel lymph ... | - | University of Chicago |